Clera home
·Dashboard

Jobs at Champions Oncology, Inc. (Now Hiring) — 3 open

Champions Oncology, Inc. logoChampions Oncology, Inc.

Project Leader, Project Leadership

Las Vegas, Nevada, United States · Remote OK

$70k–$85k/yr

Mid level$37M raised

Job DetailsLevel: ExperiencedJob Location: US Remote - Hackensack, NJ 07601Position Type: Full TimeEducation Level: Bachelors DegreeSalary Range: $70,000.00 - $85,000.00 SalaryTravel Percentage: NoneJob Shift: DayJob Cat…

Skills: Project Management, Oncology Research, In Vivo Oncology Models, Customer Service, Study Design

Champions Oncology, Inc. logoChampions Oncology, Inc.

Study Director, Project Leadership

Las Vegas, Nevada, United States · Remote OK

$80k–$110k/yr

Mid level$37M raised

Job DetailsLevel: ExperiencedJob Location: US Remote - Hackensack, NJ 07601Position Type: Full TimeEducation Level: PhDSalary Range: $80,000.00 - $110,000.00 SalaryTravel Percentage: Up to 25%Job Shift: DayJob Category: …

Skills: Preclinical Research, PDX Tumor Models, Molecular Biology, Project Management, Oncology Research

Champions Oncology, Inc. logoChampions Oncology, Inc.

Supervisor, Study Services

Rockville, Maryland, United States · On-site

$70k–$80k/yr

Senior$37M raised

Job DetailsLevel: ExperiencedJob Location: Rockville MD - Rockville, MD 20850Position Type: Full TimeEducation Level: Bachelors DegreeSalary Range: $70,000.00 - $80,000.00 SalaryTravel Percentage: NoneJob Shift: DayJob C…

Skills: In vivo Pharmacology, Oncology Studies, Staff Management, Protocol Review, SOP Development

Champions Oncology, Inc. logo

Project Leader, Project Leadership

Champions Oncology, Inc.

Las Vegas, Nevada, United States • Remote OK

Apply
Mid level

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $70k–$85k/yr
  • Full-time
  • bachelor degree, postgraduate degree
  • Posted 3d ago
  • ~40 hrs/week
  • Remote in Hackensack, New Jersey, United States

Responsibilities

The Project Leader serves as the primary scientific contact for clients, managing the design and execution of preclinical drug testing using PDX mouse platforms. They coordinate between business development and lab operations to ensure study protocols are met and final reports are delivered.

Requirements

Requires a Bachelor's degree in biological/chemical science or project management, with a Master's preferred. Candidates must have 3 to 5 years of experience in contract or pre-clinical research, specifically with in vivo oncology models.

Full job description

Job DetailsLevel: ExperiencedJob Location: US Remote - Hackensack, NJ 07601Position Type: Full TimeEducation Level: Bachelors DegreeSalary Range: $70,000.00 - $85,000.00 SalaryTravel Percentage: NoneJob Shift: DayJob Category: Biotech
TITLE AND CLASSIFICATION: Project Leader Translational Oncology Solutions

REPORTING LOCATION: US Remote

REPORTS TO: Sr Manager, Project Leadership

PRIMARY OBJECTIVESThe Project Leader (PL) serves as the primary point of contact for Champions vast portfolio of client sponsors regarding scientific design, PDX tumor model selection, and project execution. The PL is client facing and requires strong customer focus and an understanding of the needs and timelines of the client. The PL provides expertise to clients on the uses of the Tumorgraft/PDX mouse platform for preclinical drug testing. Essential job duties include preliminary client study design in collaboration with the business development team, interaction with the Lab and Facilities Operations teams to coordinate study execution, and preparing study protocols/updates/analyses/reports. Collaborates with the Business Development group to enhance client relationships and facilitate continued business for Champions Oncology. The project leader will be proactive with regards to client needs for ongoing and future studies, provide excellent customer service and mitigates miscommunications that occur in the preparation, execution and delivery of TOS projects.

DUTIES AND RESPONSIBILITIES.

Determines tumor model status and provides study timelines to BD Director for SOWs pending finalization or finalized.
Coordinates the implant of models for studies in all phases.
Participates as the technical lead in client meetings related to potential and current pre-clinical PDX opportunities.
Defines client scientific requirements and develops study design and protocols according to IACUC guidelines and operational ability.
Recommends tumor model selection based on needs and availability; suggests replacements when necessary.
Reviews SOWs to ensure pricing and scope are captured appropriately.
Ensures all necessary test agents and standards of care are in stock prior to study initiation.
Organizes kickoff and protocol review meetings with clients and internal staff.
Monitors ongoing study data to ensure tasks are being completed and any adverse events are identified and communicated to the sponsor in a timely manner.
Issues directives to the lab based on data and protocol endpoints.
Performs data and statistical analysis of study data at completion of TOS sponsor studies.
Provide weekly updates, data analysis, and final reports to clients.
Recognizes revenue for models/studies for Finance through Salesforce.
Organizes shipment of samples to the client at the end of a study.
Interfaces with Business Development, Operations, and other Champions personnel to successfully coordinate projects from start to finish.
Identifies and provides resolution to problems involving ongoing TOS studies.
Participates and provides feedback in TOS team and TOS Lab Ops/PL meetings.
Represents Champions in the field at client meetings and scientific conferences.
Identifies potential new opportunities and facilitates ongoing discussions regarding new opportunities with existing clients.
Deliver customer value in a timely manner, and ensure protocols are accurate.
Works independently
Other duties may be assigned verbally at any time.

QualificationsKNOWLEDGE, SKILLS, AND ABILITIES

Knowledge of project management and oncology research. Knowledge of in vivo oncology models (Xenograft/PDX) required.
Customer service skills, timely decision making, good interpersonal skills and an ability to be persistent while maintaining tact.
Must have the ability to balance several priorities simultaneously with high attention to detail.
Ability for frequent adaptation, self-organization, accountability.
Effective oral and written communication skills are required.
Knowledge of Microsoft Word and Excel as well as Statistical Software such as GraphPad Prism.

EDUCATION AND EXPERIENCE:

M.S degree in chemical/biological science or project management preferred.
B.S. degree acceptable with appropriate experience.
3 to 5 years of experience in the field of contract research, pre-clinical research, or a similar position

PHYSICAL DEMANDS AND WORK ENVIRONMENT:

Must be able to sit for long periods of time using a computer in a typical office environment in a home or a multi-level facility.

This description reflects management’s assignment of essential functions, it does not proscribe or restrict the tasks that may be assigned. We celebrate diversity and are committed to creating an inclusive environment for all employees.

Related keywords

BiotechTranslational OncologyPDXXenograftPre-clinical ResearchIACUC GuidelinesSOWGraphPad PrismSalesforceTumorgraftStudy ProtocolsContract ResearchIn VivoData AnalysisClient Facing

About Champions Oncology, Inc.

LinkedInVisit site

US-based, End-to-End Oncology Pharmacology Solutions CRO

Industry
Biotechnology
Company size
201-500 employees
Founded
2007
Headquarters
Hackensack, New Jersey
LinkedIn followers
11,931
Total funding
$37M

Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios. From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges. At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations. Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business. Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.

Offices: Hackensack, Hackensack, New Jersey 07601, US · 1330 Piccard Dr, Suite 025 & 104, Rockville, Maryland 20850, US · Via L. Ariosto 21, 1st Floor, Bresso MI, 20091, IT · 4 Oppenheimer St., Ha’ogen Building B, Rehovot, 7670104, IL · London, GB

Translational Oncology ResearchPersonalized OncologyPatient Derived XenograftOncology PharmacologyImmuno-OncologyFlow CytometrySyngeneic ModelsHumanized Mouse ModelsClinical Flow CytometryPDX
View all jobs at Champions Oncology, Inc.

About Champions Oncology, Inc.

LinkedInVisit site

US-based, End-to-End Oncology Pharmacology Solutions CRO

Industry
Biotechnology
Company size
201-500 employees
Founded
2007
Headquarters
Hackensack, New Jersey
LinkedIn followers
11,931
Total funding
$37M

Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios. From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges. At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations. Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business. Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.

Offices: Hackensack, Hackensack, New Jersey 07601, US · 1330 Piccard Dr, Suite 025 & 104, Rockville, Maryland 20850, US · Via L. Ariosto 21, 1st Floor, Bresso MI, 20091, IT · 4 Oppenheimer St., Ha’ogen Building B, Rehovot, 7670104, IL · London, GB

Translational Oncology ResearchPersonalized OncologyPatient Derived XenograftOncology PharmacologyImmuno-OncologyFlow CytometrySyngeneic ModelsHumanized Mouse ModelsClinical Flow CytometryPDX
View all jobs at Champions Oncology, Inc.

Similar companies hiring

Prism.bio (209)Regeneron (130)Travere Therapeutics (26)Hamilton Company (18)Xencor (13)Beeflow (13)CARSO (13)Avalo Therapeutics (9)Indica Labs (5)Acrotech Biopharma Inc (5)VTI Life Sciences (4)BioMADE (4)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Acquihire
  • Referral

Company

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Acquihire
  • Referral

Company

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty